Crossref
journal-article
Elsevier BV
Brain Research (78)
References
51
Referenced
10
10.1016/S0021-9258(18)68779-4
/ J. Biol. Chem. / Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains by Aggerbeck (1988)10.1074/jbc.271.13.7640
/ J. Biol. Chem. / Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties by Bouillot (1996)10.1523/JNEUROSCI.16-01-00186.1996
/ J. Neurosci. / Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease by Cataldo (1996){'key': '10.1016/S0006-8993(96)01445-X_BIB4', 'first-page': '763', 'article-title': 'Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease', 'volume': '92', 'author': 'Evans', 'year': '1995'}
/ Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease by Evans (1995)10.1007/BF00965328
/ Neurochem. Res. / Induction of lysosomal glycosidases by dibutiryl cAMP in neuroblastoma cells by Fischer (1986)10.1111/j.1471-4159.1989.tb11791.x
/ J. Neurochem. / Sulfation of rat apolipoprotein by Gebicke-Haerier (1989)10.1126/science.1738847
/ Science / Processing of the amyloid protein precursor to potentially amyloidgenic derivatives by Golde (1992)10.1016/S0021-9258(19)39699-1
/ J. Biol. Chem. / Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and acceterates receptor degradation by Grant (1990)10.1016/0197-4580(94)00172-W
/ Neurobiol. Aging / Secreted beta-APP stimulates MAP kinase and phosphorylation of tau in neurons by Greenberg (1995)10.1038/357500a0
/ Nature / Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments by Haass (1992)10.1038/nm1295-1291
/ Nature Med. / The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway by Haass (1995)10.1016/S0022-2275(20)41390-2
/ J. Lipid Res. / Effects of apolipoprotein E. β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal noo ganglion neurons in vitro by Handelmann (1992)10.1016/0006-291X(92)90437-P
/ Biochem. Biophys. Res. Common. / Protease inhibitors generate cytotoxic fragments from Alzheimer amyloid protein precursor in cDNA-transfected glioma cells by Hayashi (1992)10.1016/0022-2836(92)90835-8
/ J. Mol. Biol. / Substitutions of hydrophobic amino acides reduce the amyloid-genicity of Alzheimer's disease beta A4 peptides by Hilbich (1992)10.1016/0076-6879(86)29091-6
/ Methods Enzymol. / Lipoprotein-receptor interactions by Innerarity (1986)10.1016/0092-8674(93)90635-4
/ Cell / Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? by Jarrett (1993)10.1016/0092-8674(95)90320-8
/ Cell / LDL receptor-related protein, a multifunctional apoE, receptor, binds secreted β-amyloid precursor protein and mediates its degradation by Kounnas (1995)10.1016/S0021-9258(17)31529-6
/ J. Biol. Chem. / Isoform-specific binding of apolipoprotein E to β-amyloid by LaDu (1994)10.1074/jbc.270.16.9039
/ J. Biol. Chem. / Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid by LaDu (1995)10.1038/nsb1195-990
/ Nature Struct. Biol. / Structural model for the β-amyloid fibril based on interstrand alignment of an anti-parallel-sheet comprising a C-terminal peptide by Lansbury (1995)10.1002/jnr.490350411
/ J. Neurosci. Res. / p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons by Lu (1993)10.1126/science.3283935
/ Science / Apolipoprotein E: cholesterol transport protein with expanding role in cell biology by Mahley (1988)10.1016/0196-9781(94)90188-0
/ Peptides / Hydrolysis of amyloid precursor protein-derived peptides by cysteine proteinases and extracts of rat brain clathrin-coated vesicles by Marks (1994)10.1111/j.1399-3011.1995.tb00602.x
/ Int. J. Pept. Protein Res. / Brain cathepsin B but not metalloendopeptidases degrade rAPP251 with production of amyloidogenic fragments. Comparison with synthetic peptides emulating β- and γ-secretase sites by Marks (1995)10.1074/jbc.270.45.26727
/ J. Biol. Chem. / Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein by Martin (1995)10.1016/0006-8993(91)91092-F
/ Brain Res. / Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease by Namba (1991)10.1016/0896-6273(95)90079-9
/ Neuron / Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain by Naslund (1995)10.1126/science.8171342
/ Science / Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro by Nathan (1994)10.1016/S0021-9258(18)54194-6
/ J. Biol. Chem. / Identification of the Alzheimer β/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells by Nordstedt (1993)10.1074/jbc.271.15.9100
/ J. Biol. Chem. / Enhanced release of amyloid β-protein from codon 670671 “Swedish” mutant β-amyloid precursor protein occurs in both secretory an endocytic pathways by Perez (1996)10.1523/JNEUROSCI.13-04-01676.1993
/ J. Neurosci. / Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state by Pike (1993)10.1046/j.1471-4159.1995.64010253.x
/ J. Neurochem. / Structure activity analyses of β-amyloid peptides: contributions of the β(25–35) region to aggregation and neurotoxicity by Pike (1995)10.1097/00019052-199508000-00004
/ Curr. Opin. Neurol. / Amyloid β amyloidosis in Alzheimer's disease by Price (1995)10.1016/0076-6879(86)28073-8
/ Methods Enzymol. / Isolation and characterization of apolipoprotein E by Rall (1986)10.1016/0896-6273(93)90070-8
/ Neuron. / Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions by Rebeck (1993)10.1172/JCI117407
/ J. Clin. Invest. / Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 by Sanan (1994)10.1002/jnr.490370307
/ J. Neurosci. Res. / Amyloid precursor protein is enriched in axolemma and periaxolemma-myelin and associated clathrin-coated vesicles by Sapirstein (1994)10.1002/jnr.490350110
/ J. Neurosci. Res. / Identification of membrane-bound carbonic anhydrase in white matter coated vesicles: the fate of carbonic anhydrase and other white matter coated vesicles proteins in triethyl tin-induced leukoencephalopathy by Sapirstein (1993){'issue': 'Suppl. 1', 'key': '10.1016/S0006-8993(96)01445-X_BIB39', 'first-page': 'S27', 'article-title': "Coated vesicles as a model of Alzheimer's disease", 'volume': '66', 'author': 'Sapirstein', 'year': '1996', 'journal-title': 'J. Neurochem.'}
/ J. Neurochem. / Coated vesicles as a model of Alzheimer's disease by Sapirstein (1996)10.1046/j.1471-4159.1994.63041191.x
/ J. Neurochem. / Structural determinants of the Alzheimer's amyloid β-peptide by Soto (1994){'key': '10.1016/S0006-8993(96)01445-X_BIB41', 'first-page': '4725', 'article-title': 'Apolipoprotein E and Alzheimer disease', 'volume': '92', 'author': 'Strittmatter', 'year': '1995'}
/ Apolipoprotein E and Alzheimer disease by Strittmatter (1995){'key': '10.1016/S0006-8993(96)01445-X_BIB42', 'first-page': '11183', 'article-title': 'Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease', 'volume': '91', 'author': 'Strittmatter', 'year': '1994'}
/ Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease by Strittmatter (1994){'key': '10.1016/S0006-8993(96)01445-X_BIB43', 'first-page': '8098', 'article-title': 'Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease', 'volume': '90', 'author': 'Strittmatter', 'year': '1993'}
/ Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease by Strittmatter (1993)10.1083/jcb.111.3.929
/ J. Cell Biol. / Endocytosed β-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages by Tabas (1990)10.1006/jmbi.1995.0525
/ J. Mol. Biol. / Self-association of β-amyloid peptide (1–40) in solution and binding to lipid membranes by Terzi (1995)10.1074/jbc.271.16.9390
/ J. Biol. Chem. / Metabolism of the “Swedish” amyloid precursor protein variant in Neuro2a (N2a) cells. Evidence that cleavage at the “β-secretase” site occurs in the Golgi apparatus by Thinakaran (1996)10.1016/S0065-3233(08)60642-7
/ Adv. Protein Chem. / Apolipoprotein E: structure-function relationships by Weisgraber (1994)10.1016/S0021-9258(18)99060-5
/ J. Biol. Chem. / Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity by Weisgraber (1991)10.1002/jnr.490330202
/ J. Neurosci. Res. / β/A4 domain of APP: antigenic differences between cell lines by Wolozin (1992)10.1016/0165-6147(88)90078-8
/ Trends Pharmacol. Sci. / Regulation of endocytic processes by pH by Yamashiro (1988)10.1083/jcb.117.1.39
/ J. Cell Biol. / Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice by Yokode (1992)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 6:02 p.m.) |
Deposited | 4 years, 3 months ago (May 12, 2021, 4:59 a.m.) |
Indexed | 2 years ago (Aug. 25, 2023, 6:01 p.m.) |
Issued | 28 years, 6 months ago (March 1, 1997) |
Published | 28 years, 6 months ago (March 1, 1997) |
Published Print | 28 years, 6 months ago (March 1, 1997) |
@article{Berg_1997, title={Composition of white matter bovine brain coated vesicles: evidence that several components influence β-amyloid peptide to form oligomers and aggregates in vitro}, volume={752}, ISSN={0006-8993}, url={http://dx.doi.org/10.1016/s0006-8993(96)01445-x}, DOI={10.1016/s0006-8993(96)01445-x}, number={1–2}, journal={Brain Research}, publisher={Elsevier BV}, author={Berg, Martin J. and Durrie, Robert and Sapirstein, Victor S. and Marks, Neville}, year={1997}, month=mar, pages={72–80} }